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INSIGHTS FROM MODEL SYSTEMS
A Model of Elegance
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To start with we propose to identify every cell in the worm and trace lineages.
We shall investigate the constancy of development and study its genetic
control by looking for mutants. (Sidney Brenner)
Since Sidney Brenner wrote this statement in a vision-
ary research proposal addressed to Max Perutz 35 years
ago (Wood 1988, p. xiii), an enormous amount of
information has been gathered on the biology of the
nematode Caenorhabditis elegans (“the worm”), both
fulfilling his predictions and exceeding his original ex-
pectations. Researchers have identified every cell in the
worm and have described all the lineages by which these
cells are formed (Horvitz and Sulston 1980; Sulston et
al. 1983; Wood 1988). Adult hermaphrodites contain
959 somatic nuclei, which are organized into differen-
tiated tissue types such as muscle, intestine, epidermis,
and nervous system. The latter is composed of 302 neu-
rons that are connected by ∼7,500 synaptic junctions
(Wood 1988). The function of many individual cells has
been inferred from ablation experiments using laser-
beam technology (e.g., see Bargmann and Avery 1995).
Genes involved in development and behavior have
been identified through the analysis of mutations that
affect these functions. The number of genes identified
genetically has increased from the original 103 described
by Brenner (1974) to the ∼1,600 complementation
groups known at present (Hodgkin 1997). A compre-
hensive genetic map has been compiled and continues
to expand. A detailed physical map of overlapping cos-
mids and YACs covers the genome almost entirely (Coul-
son et al. 1995). Finally, the genome sequence is expected
to be completed by the end of this year (Hodgkin et al.
1995).
The availability of the complete C. elegans genome
sequence will not only benefit worm researchers but will
also undoubtedly be useful for the elucidation of human
gene function. Thus, in addition to providing funda-
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mental information on how a small, free-living animal
develops and responds to its environment, the worm field
is now recognized as potentially useful in the under-
standing of the development and behavior of humans.
Again as Brenner put it, “our field has prospered and
has come of age; what was once a joke organism)has
now become a major experimental system for the study
of development” (Wood 1988, p. ix). Not only can the
results obtained in C. elegans teach us about the mech-
anisms that underlie normal development, but they can
also be very useful in the study of biochemical mecha-
nisms underlying devastating human diseases. Moreover,
the worm system has the potential to become a conven-
ient tool for the design of therapeutic strategies required
for the treatment of these diseases.
For these reasons, the readers of the Journal might be
interested in an overview of C. elegans genetics and gen-
omics and of how worm biology can benefit their
research. Here, we place particular emphasis on the
benefits of the study of worm gene functions and inter-
actions to the understanding of human biology; on the
importance of the genomic information that should soon
become available for C. elegans; and on the promise of
the worm as a model for drug discovery.
Searching for Elegance
Defining the mechanism of the action of human genes
can be extremely difficult, because of the complexity of
human biology and the lack of reliable tools to selec-
tively alter gene function in vivo, not to mention obvious
ethical constraints. Since entire protein complexes and
biochemical pathways appear to be conserved between
humans and relatively simple model organisms, many
laboratories have turned to such organisms, with the
goal of establishing functional models that can ulti-
mately teach us about human biology. A number of ex-
cellent recent reviews describe the experimental features
of the worm and detail its virtues as a model organism
(Hodgkin et al. 1995; Plasterk 1996; Ahringer 1997;
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Kuwabara 1997). In addition, three books are available
in which most of the current biological information and
detailed protocols can be found (Wood 1988; Epstein
and Shakes 1995; Riddle et al. 1997).
The worm model combines ease of genetic manipu-
lations with the ability to address biological questions
related to development, behavior, and cancer. Caenor-
habditis elegans genetics is very convenient. For exam-
ple, worm cultures can be grown easily in the lab, and
strains of interest can be stored frozen (Epstein and
Shakes 1995). Since most adult worms develop into self-
fertilizing hermaphrodites, it is usually trivial to obtain
F2 animals homozygous for a mutation of interest.
Moreover, males can also be obtained, which allows
the exchange of genetic material by cross-fertilization.
Transgenic animals can also be generated by injection
of cloned DNA (a gene, a cDNA, a cosmid, or a YAC),
along with a dominant marker, into the germ line. The
resulting transgenes are transmitted in the form of ex-
trachromosomal DNA arrays. Although this technique
does not allow cloning of genes by complementation
using cDNA libraries, it is very useful for determination
of which of several candidate DNA fragments can rescue
the phenotype of loss-of-function mutations (Mello et
al. 1991; Epstein and Shakes 1995). Finally, as discussed
below, gene function can be analyzed by relatively con-
venient antisense technologies.
Having a BLAST
Usually the first reaction of a human gene cloner in
the seconds following the pile-up and translation of a
long-awaited DNA sequence is to “BLAST” the pre-
dicted protein sequence against the available databases,
with the hope of finding statistically significant homol-
ogies. With the complete genomic sequence in hand, it
will be possible to determine, in silico, the existence of
all potential orthologues in C. elegans (“comparative
genomics”). The proportion of positionally cloned hu-
man disease genes that show significant homology
( ) to potential worm orthologues is cur-10P ! 1# 10
rently 63% (Bassett et al. 1995, 1997; also see the
XREFdb Website). This proportion drops to 38% for
potential fly orthologues, probably because the genome-
sequence project is less advanced in that organism. It is
35% for yeast proteins, since the evolutionary diver-
gence is greater (in this case, despite the availability of
its entire genome sequence). Until the complete genomic
sequence of the worm is released into GenBank, it re-
mains more advantageous to search for worm ortho-
logues directly in the databases available from the two
sequencing centers involved in the project (The Sanger
Center and the Genome Sequencing Center, University
of Washington School of Medicine).
Once a potential worm orthologue has been identified,
ACeDB (A C . elegans Database) (Durbin and Thierry-
Mieg 1994) can be used to fetch the information nec-
essary to start work with the orthologue corresponding
to the gene of choice. For simplicity, ACeDB can be
thought of as an organized repository matrix composed
of predicted open reading frames (ORFs) in one axis and
the relevant information in the other. Just to name a few
options, it is possible to find, for each locus, the available
information on the genetic-map position and on neigh-
boring genes, the different cosmids and YACs covering
the region on the physical map, the genome sequence
with the predicted ORFs and predicted intron/exon
boundaries, and the availability and sequence of cor-
responding expressed sequence tags (ESTs) as a confir-
mation of the intron/exon structure. An excellent
summarized version of a “guided tour” in ACeDB is
available in a recent review (Kuwabara 1997).
1% Inspiration, 99% Perspiration
How can C. elegans be used to elucidate the function
of a particular human disease protein (HDP)? One ap-
proach consists in finding a potential worm orthologue
of HDP (WHD-1) in silico (see above) and analyzing the
in vivo phenotype(s) resulting from the abrogation of its
function. In addition to providing critical functional in-
formation, such phenotype(s) can eventually be used in
genetic screens to identify interacting genes. Although
convenient, such screens are not trivial and usually re-
quire the construction of strains that carry particular
alleles; partial loss-of-function alleles are generally pre-
ferred, especially when the wild-type gene is essential for
development or when one wishes to identify both en-
hancers and suppressors of an intermediate phenotype.
The phenotypes that arise from loss of WHD-1 activity
in the worm generally will not resemble the overt human
disease phenotypes, but there will often be similarities
at the subcellular or biochemical level, which afford in-
sights into the molecular mechanisms of the disease. One
example of this is the elucidation of some of the mo-
lecular mechanisms involved in the function of the hu-
man ras oncogene, by the analysis of the role of its C.
elegans orthologue, let-60, in vulva development (Kayne
and Sternberg 1995; Kornfeld 1997).
Finding a worm orthologue of HDP can be followed
by a number of different approaches. In the most pow-
erful scenario, whd-1 has already been identified by clas-
sic forward genetics and subsequently has been cloned
and sequenced. Previous identification of a gene by for-
ward genetics means that a particular phenotype(s) has
already been associated with the loss of its function
(whd-1(lf)). An optimal disease model can be generated
if HDP can functionally substitute for WHD-1. For ex-
ample, the worm sel-12 gene encodes a protein that
shares 50% identity with two human presenilins in-
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volved in Alzheimer disease. The egg-laying–defective
phenotype of sel-12(lf) mutants is rescued by wild-type
human presenilin but not by the mutant alleles found in
Alzheimer patients (Levitan and Greenwald 1995; Lev-
itan et al. 1996). It should be stressed that a negative
result in such rescue experiments is not sufficient to rule
out the possibility of a functional conservation between
HDP and WDP.
In a second scenario, whd-1 is already known through
classic forward genetics, but the gene remains uncloned
(of 1,600 complementation groups identified, ∼500 have
been cloned). In some cases, the physical position of
whd-1 might point to a few mutations located in the
corresponding area of the genetic map and representing
potential whd-1 loci. The functional rescue, by wild-type
whd-1, of one of these mutations then provides evidence
that the whd-1 gene corresponds to a particular com-
plementation group. Although potentially powerful, this
approach can be complicated in regions of the genetic
map that are characterized by a high density of potential
loci.
In the third, and most likely, scenario, whd-1 has not
been identified by forward genetics, and there is virtually
no functional information available. In this case, phe-
notypes associated with the loss of whd-1 will have to
be uncovered. A technique called “RNA-mediated in-
terference” (RNAi) is very powerful in this respect. An-
tisense, sense, or double-stranded whd-1 RNA injected
into the germ-line syncytium of an adult hermaphrodite
is often found to impede whd-1 function in the progeny
(Guo and Kemphues 1995; Rocheleau et al. 1997; Fire
et al. 1998). The effect is likely specific, since the RNAi
phenotype often resembles that of loss-of-function mu-
tations. The effect of RNAi is not limited to embryos
but is transmitted through larval development and adult-
hood, for several generations. In general, however, the
effect of RNAi cannot be propagated for many gener-
ations, so subsequent genetic analyses, such as enhancer
and suppressor screens, are not possible. Such screens
depend on the availability of whd-1 null or partial loss-
of-function alleles.
Two methods are available to create whd-1 null al-
leles. The first method is based on the ability to isolate
a worm strain with the Tc1 transposable element in-
serted within whd-1 and subsequent screening by PCR
for imprecise excision leading to a deletion in whd-1
(Zwaal et al. 1993). Although this method was very
promising, it is now being replaced by a more efficient
method, based on the use of a chemical mutagen to
create libraries of deletion alleles (Jansen et al. 1997).
Again in this case, strains containing deletions in whd-
1 are identified by a PCR reaction. The number of genes
that have been deleted this way increases rapidly.
If neither RNAi nor the deletion of whd-1 confers a
detectable phenotype, then a few more tools based on
the localization of expression of whd-1 are available to
aide in the formulation of hypotheses about the function
of the gene. Whole-mount techniques are available for
RNA in situ hybridization that are useful for the local-
ization of expression down to single cells. More con-
veniently, transgenic animals can be generated that ex-
press b-galactosidase or green fluorescent protein (GFP)
under the control of a whd-1 promoter, or as a fusion
with the whd-1 gene product. Gene expression, as de-
tected by the reporter construct, can then be used to
screen for phenotypes in a more subtle way (Chalfie et
al. 1994; Troemel et al. 1995)
If the human disease is caused by a gain-of-function
mutation in HDP, one or more worm orthologues might
also be identified and tested as described above. How-
ever, a more direct approach is to generate transgenic
animals that overexpress the mutant dominant gain-of-
function version of HDP and to analyze the resulting
phenotype. In principle, these animals can also be used
in screens to identify genetic interactors and to elucidate
HDP function.
The Worm Available at the Click of a Mouse
Despite the power of genetics and cell biology avail-
able in model organisms such as the worm, the number
of genes with a function assigned is still relatively small,
compared with the invested efforts. The ∼500 cloned C.
elegans genes that correspond to genetically identified
complementation groups represent ∼4% of the expected
13,000 genes. Hence, it seems crucial to design comple-
mentary approaches to increase the speed of gene-func-
tion discovery. The current explosion of complete ge-
nome sequences should facilitate such global approaches
(Lander 1996; Fields 1997).
With this in mind, several labs, including our own,
are specializing in the generation of resources and func-
tional information on a genomewide scale (a field that
is often referred to as “functional genomics”). Support-
ing evidence for the necessity of such projects can be
found in the genomic sequencing projects of several
model organisms, which have taught us several lessons.
First, it is very cost-efficient to centralize the efforts of
repetitive experiments such as sequencing (Hodgkin et
al. 1995). Since functional studies can also be somewhat
repetitive (see below), the same principle should apply
to functional genomics projects. Second, novel interest-
ing and somewhat unexpected aspects of biology have
emerged from genomewide projects. For example, the
complete sequencing of the yeast genome has revealed
that it derives from a duplication (Wolfe and Shields
1997). It is possible that new principles might similarly
emerge from large-scale functional genomics analyses.
Finally, standardized, or even automated, methods and
computer tools that generate, analyze, or access sequence
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The Two-Hybrid System: Forward and Reverse
The two-hybrid system makes use of the fact that regulatory
transcription factors are generally composed of two separable
domains: a sequence-specific DNA-binding domain (DB) and a
transactivation domain (AD) (Keegan et al. 1986). Neither DB
nor AD activates transcription unless they are held together
(Triezenberg et al. 1988), so, when two proteins (X and Y) are
expressed as hybrid proteins, one of which is fused to DB (DB-
X) and the other of which is fused to AD (AD-Y), a physical
interaction between X and Y can be identified through the re-
constitution of a functional transcription factor (Fields and
Song 1989). In “forward” two-hybrid screens, one selects for
protein-protein interactions, using a positive selectable reporter
gene which must be activated to allow cell growth under specific
conditions. When applied to a large-scale project, such as the
generation of a comprehensive protein-interaction map, high
rates of false-positives, as observed in many conventional two-
hybrid screens, can obscure genuine interactions. However,
common causes of false positives have been eliminated by op-
timizing the assay in advance (see, e.g., Vidal and Legrain 1998).
Beyond the need to optimize the forward two-hybrid assay
is the fact that the system inherently lacks direct connections
with the biological processes for validation of potential inter-
actions. One approach for validation consists in observing the
effect of disrupting a potential interaction in vivo in the relevant
model organism. To this end, we have developed a “reverse”
two-hybrid system that can select for interaction-defective al-
leles (IDAs) and for trans-acting molecules that specifically dis-
sociate protein-protein interactions (Vidal 1997). Here, the
inducible reporter gene encodes a protein that is toxic under
specific conditions, allowing selection against protein-protein
interactions (Vidal et al. 1996a, b). Our current challenge is to
examine whether IDAs and/or dissociating molecules will be
useful to validate worm protein-protein interactions. For ex-
ample, IDAs of WHD-1 might be compared to the wild type
for their ability to rescue the phenotype(s) conferred by whd-
1(lf). In addition, dissociating peptides or compounds could be
tested for their ability to “phenocopy” thewhd-1(lf) phenotype.
data might be applicable to large-scale projects aimed
at the elucidation of gene function. Importantly, func-
tional genomics projects in model organisms will make
available both materials and information of great po-
tential biological or clinical interest. Much of the infor-
mation revealed by time-consuming experiments in the
worm might soon be retrieved by no more than a click
of a computer mouse.
The complete genome sequence of all six chromo-
somes inC. eleganswill lead to ∼13,000 ORFs, predicted
by a program called Genefinder. It has been estimated
that !3,000 of these ORFs are essential (Hodgkin et al.
1995). Although the genome sequence itself is very ac-
curate (199.9%), Genefinder correctly predicts the in-
tron/exon junctions in ∼50% of the cases. However, a
large-scale project of EST sequencing is expected to lead
to definitive answers on the genomic structure and ex-
pression of many predicted ORFs. For example, it is
possible that computer-predicted ORFs might not be ex-
pressed in vivo and therefore might not represent gen-
uine genes, whereas other sequences that could not be
recognized by Genefinder might indeed be expressed. In
addition, genes may have an intron/exon structure dif-
ferent than that predicted by the program. The EST in-
formation currently available can be accessed in ACeDB.
The yeast model system, with the first eukaryotic ge-
nome sequenced (Goffeau et al. 1996), already provides
a great example for the development of functional gen-
omics projects: (i) genomewide expression analysis using
DNA arrays representing every single predicted yeast
ORF is possible (Schena et al. 1995); (ii) a consortium
is making progress in deleting every single predicted
ORF (e.g., see Smith et al. 1996); and (iii) a protein-
interaction map is underway (Evangelista et al. 1997;
Fromont-Racine et al. 1997).
Similar projects are now underway in C. elegans. Pro-
jects to delete every single predicted ORF or aimed at
the identification of every ORF essential for worm de-
velopment and using RNAi are in the planning stage (A.
Coulson, R. Plasterk, and A. Hyman, personal com-
munication), and aC. elegans cDNA array, which should
be useful for the creation of expression maps, is also
under development (S. Kim, personal communication).
Other projects are underway to determine in what cell
and at what stage of development each ORF is expressed
(e.g., see Tabara et al. 1996).
Because protein-protein interactions are important for
most biological functions, we have initiated a large-scale
project to generate a protein-interaction map for C. ele-
gans. Protein-interaction maps are defined here as pub-
licly available databases in which information on po-
tential protein-protein interactions can be found. Like
other functional genomics resources, protein-interaction
maps could produce functional information available at
the click of a mouse. Together with additional infor-
mation such as cellular localization or time of expres-
sion, they would lead to the formulation of hypotheses
that could be tested in the relevant biological system.
The two-hybrid system has been proved useful for the
identification of protein-protein interactions (for a recent
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Figure 1 Anticipated in silico approaches, on finding a worm
orthologue of HDP. A BLAST search with the translated HDP protein
sequence will, in many cases, reveal at least one worm orthologue
(whd-1). In an ideal worm functional genomic database, information
will be readily available on several aspects of whd-1, such as its ex-
pression during development and in specific cell types, the phenotypes
associated with loss of whd-1 function, genetic interactions of whd-
1, EST clones available, intracellular localization of the WHD-1 pro-
tein, and potential WHD-1 interacting proteins. In addition, this in-
formation can be compared with data available from other model
organisms and should guide biologists in the forming of new and
testable hypotheses on the molecular basis of a relevant human trait
or disease.
review, see Vidal and Legrain 1998). However, the sys-
tem can also be complicated by high numbers of false
positives and can be limited by the lack of direct con-
nections with biology. As shown in the sidebar we are
addressing these two issues by integrating “forward”
and “reverse” versions of the two-hybrid strategy with
classical genetics available in the nematode. A protein-
interaction map forC. elegans should nicely complement
the information generated by a yeast protein-interaction
mapping project. Although valuable in itself—and, in
some ways, more tractable—the yeast protein-interac-
tion project cannot be expected to elucidate interactions
among proteins that arose during animal evolution. Fur-
thermore, the technical challenges posed both by the
worm’s larger genome and by the greater prevalence of
introns in C. elegans genes compared with yeast genes
make the worm project a closer model for some future
endeavor, to map human protein interactions.
Looking for Drugs
Conventional drug-screening programs may lead to
the identification of compounds that prove to be im-
practical as therapeutics, often because in vitro assays
are inadequate to predict activity in a physiological set-
ting. Some compounds score very well in terms of se-
lectivity and sensitivity in vitro but are unstable or only
poorly available to target tissues. Furthermore, screens
performed in vitro can be costly and time-consuming.
For these reasons, screens for compounds increasingly
rely on the use of in vivo, cell-based assays.
It has been suggested that C. elegans could be a pow-
erful system for in vivo drug-screening assays (Rand and
Johnson 1995). For example, if either loss-of-function
of whd-1 or overexpression of HDP confers detectable
phenotypes, libraries of compounds could be screened
for molecules that partially rescue these phenotypes.
Thereby, a “worm disease model” might assist in the
development of therapeutic strategies and might repre-
sent a rather inexpensive and convenient way to screen
hundreds of thousands of compounds. Moreover, unlike
conventional in vitro screening programs, the resulting
molecules would have been prescreened for their in vivo
stability, ability to diffuse through a multicellular or-
ganism, and competence to penetrate cells. A drug that
fulfills all of these criteria in worms should then be tested
in a rodent or primate system before being tested on
human patients.
A potential problem of nematode-based drug-screen-
ing systems is that the worm, with its relatively thick
cuticle, is not sufficiently permeable to certain drugs.
However, a few published test cases indicate that, at least
at relatively high concentrations, some drugs will pen-
etrate the animal. For example, a Ras farnesyltransferase
inhibitor is capable of suppressing the multivulva phe-
notype caused by expression of let-60(gf), an activated
ras allele that is analogous to those found in many hu-
man cancers (Hara and Han 1995). In other experi-
ments, mutations conferring resistance and/or hypersen-
sitivity to certain drugs have been identified, and the
corresponding genes have been characterized. For ex-
ample, the analysis of mutants resistant to a cholines-
terase inhibitor has uncovered genes involved in synaptic
vesicle function and in metabolism of acetylcholine (Mil-
ler et al. 1996). Other examples of drugs for which the
approach has been tested include Prozac (Weinshenker
et al. 1995), halothane, and other volatile anesthetics
(van Swinderen et al. 1997). These studies support the
potential use of the worm as a drug-screening tool.
Conclusion
In addition to currently available in silico techniques
to reveal WHD-1 as a potential orthologue of an im-
portant HDP, functional data will eventually be available
to gene cloners, for use in the prediction of the pathway
in which WHD-1 acts in nematodes. They will also learn,
with little effort, the cell types, the stage of development
in which it is expressed, and the phenotype conferred
by a whd-1 loss-of-function mutation (fig. 1). Although
this information will not reveal the precise function of
HDP, it will surely provide a basis for the generation of
hypotheses that can then be tested in the relevant human
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biological systems. In addition, it will be interesting to
see whether the worm model will be used widely to
design novel therapeutic strategies.
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